1. Home
  2. EUDA vs ITRM Comparison

EUDA vs ITRM Comparison

Compare EUDA & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$18.43

Market Cap

24.3M

Sector

Finance

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
ITRM
Founded
2021
2015
Country
Singapore
Ireland
Employees
117
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
EUDA
ITRM
Price
$18.43
$0.03
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$55.00
$9.00
AVG Volume (30 Days)
34.4K
30.9M
Earning Date
12-19-2023
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$134.73
N/A
Revenue Next Year
$195.03
$947.65
P/E Ratio
$123.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.03
52 Week High
$25.70
$1.16

Technical Indicators

Market Signals
Indicator
EUDA
ITRM
Relative Strength Index (RSI) 70.34 26.10
Support Level $2.07 N/A
Resistance Level $18.90 $0.39
Average True Range (ATR) 1.03 0.02
MACD 0.05 -0.01
Stochastic Oscillator 89.20 3.34

Price Performance

Historical Comparison
EUDA
ITRM

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: